Skip to main content

Dynamic Coagulation Deterioration and Cumulative Burden Preceding Noncoagulation Organ Dysfunction in Sepsis: A Two-Database Cohort Study

In brief

Persistent coagulation abnormalities tracked with 6% higher organ-dysfunction risk in sepsis

In a sepsis cohort, each standard-deviation increase in cumulative coagulation abnormality over the first 24 hours was associated with about 6% higher risk of later organ dysfunction, even after strict accounting for treatment and devices. Associations were strongest for liver and kidney worsening; the primary measure of short-term deterioration was weaker, and prospective studies are needed to confirm these observational findings.

Journal
Journal of clinical medicine (Q1)
Published
26 October 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Xiang Li, Jingjing Dai, Xilei Cai, Xuejiao Ma, Yunzhu Zhu, Jiabin Li
PMID
43030470
DOI
10.3390/jcm15218326

Why clinicians should know about it

  • Picked for Nephrology (paper of the day, 15 November 2026): Sepsis-associated organ dysfunction includes renal worsening

Abstract

Background: Static coagulation measurements cannot distinguish transient fluctuation from sustained abnormality in sepsis. We assessed whether 0-24 h dynamic coagulation phenotypes preceded noncoagulation organ dysfunction during 24-72 h. Methods: We conducted a retrospective cohort study using the Medical Information Mart for Intensive Care IV (MIMIC-IV) for development and the eICU Collaborative Research Database (eICU-CRD) for component-level replication. Platelet count, international normalized ratio (INR) and partial thromboplastin time (PTT) were aligned to fixed 6 h grids. The two-marker coagulation deterioration index (CDI2) was the prespecified primary exposure; coagulation instability, recovery and cumulative coagulation burden (CCB) were prespecified secondary phenotypes. Modified Poisson models estimated adjusted risk ratios (aRRs) with 95% confidence intervals (CIs). Trajectories incorporating measurements after 24 h were excluded from temporally ordered association and prediction models. Results: Among 13,669 eligible MIMIC-IV sepsis stays, 2208 had complete five-organ outcome assessment; 1278 (57.9%) developed the composite. In the primary CDI2 analysis (n = 1002; 619 events), each MIMIC standard deviation was associated with the composite (aRR 1.051, 95% CI 1.007-1.098), but the strict treatment/device-truncated estimate attenuated (aRR 1.018, 95% CI 0.966-1.074). Prespecified secondary CCB2 was associated in observed care (n = 2185; aRR 1.076, 95% CI 1.033-1.122), remained associated after strict truncation (aRR 1.061, 95% CI 1.006-1.119), and was robust to measurement-intensity adjustment and selection weighting (aRR 1.089, 95% CI 1.009-1.175). CCB2 showed the largest associations with liver and renal worsening; these persisted after excluding cirrhosis and baseline liver dysfunction and were directionally reproduced for eICU kidney and liver components. Conclusions: The prespecified primary directional-deterioration signal was small and sensitive to treatment/device truncation. Prespecified secondary analyses consistently indicated that persistence of coagulation abnormality was more informative than short-term direction, particularly for hepatic and renal deterioration. These associative findings apply principally to patients with sufficient coagulation and organ monitoring and require prospective confirmation.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.